A Study of AL721 in HIV-Infected Patients With Swollen Lymph Nodes

NCT00001012 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: AL 721

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)